ArticleAME case reports2026
Advanced rectal cancer with multiorgan metastasis detected after single fetal death in twin pregnancy: a case report.
Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Detection of colorectal cancer (CRC) during pregnancy is rare; moreover, its diagnosis is often delayed because its symptoms overlap with the physiological changes that occur during gestation. Reports of pregnancies complicated by advanced malignancy in which non-reassuring fetal status (NRFS) occurred are rare. Case Description: Herein, we report a case involving a twin pregnancy in which single fetal death served as a crucial clue for the detection of advanced CRC with multiorgan metastasis. A 36-year-old pregnant woman was admitted at 26 weeks and 3 days with suspected preterm contractions, a NRFS with elevation of inflammatory markers or activated coagulation. Despite thorough monitoring, intrauterine fetal death (IUFD) was observed for Fetus I at 28 weeks and 0 days. Imaging studies performed to investigate the fetal death and maternal inflammation revealed multiple masses in the liver. At 28 weeks and 2 days of gestation, findings suggestive of NRFS were observed for Fetus II. Emergency cesarean section was performed on the same day. Histopathology of both placentas demonstrated extensive infarctions. Following delivery, a thorough examination of the maternal liver led to a diagnosis of advanced CRC with multiple metastases. The patient underwent chemotherapy but succumbed to progressive disease 13 months later. Placental dysfunction due to maternal malignancy-associated hypercoagulability was considered the likely mechanism of IUFD. Conclusions: In cases of advanced cancer during pregnancy, attention must also be paid to fetal-placental function. In pregnant women, when IUFD occurs accompanied by unexplained maternal inflammatory response elevation and coagulation activation, thorough investigation for malignant tumors is necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.